ISSN 0975-3583
 

Journal of Cardiovascular Disease Research

2021, Vol: 8, Issue: 8
Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles
Required files to be uploaded

Copyright


    Assessment of prevalence of the metabolic syndrome in COPD patients and its correlation with severity of COPD and components of metabolic syndrome


    Dr. Deepak Kumar, Dr. Ram Gopal Nautiyal, Dr. Dinesh Chandra Punera, Dr. Sandeep Raj Saxena, Dr. Anshul Kediya, Dr. Atul Upadhyay
    JCDR. 2023: 1277-1284

    Abstract

    Extrapulmonary consequences of COPD appears to be linked to systemic inflammation. Metabolic syndrome represents a cluster of risk factors that increases the risk for developing various non-communicable diseases. It is currently unclear how metabolic syndrome, a significant factor in systemic inflammation in general population, and COPD are related. Aim: To assess the prevalence of the metabolic syndrome in COPD patients and its correlation with severity of COPD and components of metabolic syndrome. Methodology: The present study was a cross-sectional observational study. Patients were included after performing spirometry. All demographic data, anthropometric and laboratory parameters were recorded. COPD severity level was determined according to GOLD 2021 guideline. Metabolic syndrome was identified according to South Asian Modified National Cholesterol Education Program criteria. Statistical analysis was done using Statistical Package for the Social Sciences (SPSS) 21. Comparison of quantitative variables between the study groups was done using the Student t-test. Results: A total of 183 COPD patients, confirmed by spirometry, from January 2021 to September 2022 were included in the study. In 34.42% of COPD patients, metabolic syndrome was recorded. Males outnumbered females. Amongst 63 COPD patients with metabolic syndrome, 74.60% were males and 25.39% were females. Amongst 120 COPD patients without metabolic syndrome 74.16% were males and 25.83% were females. COPD patients with metabolic syndrome had significant association with high BMI, more waist circumference, elevated SBP and DBP, elevated FBS, elevated serum TG and low serum HDL as compared to COPD patients without metabolic syndrome. Most of the (49.20%) COPD patients with metabolic syndrome were in GOLD stage III followed by stage II (39.68%), stage IV (9.52%) and stage I (1.58%). While most of the (50.83%) COPD patients without metabolic syndrome were in GOLD stage III followed by stage II (40.83%), stage IV (6.66%) and stage I (1.66%).

    Description

    » PDF

    Volume & Issue

    Volume 14 Issue 3

    Keywords
Submit Article
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.
The articles in Journal of Cardiovascular Disease Research are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Copyright � 2022 Journal of Cardiovascular Disease Research All Rights Reserved. Subject to change without notice from or liability to Journal of Cardiovascular Disease Research. For best results, please use Internet Explorer or Google Chrome


POLICIES & JOURNAL LINKS

Contact Information


Journal of cardiovascular Disease Research,
No: 763-1/A Gandhi Road-2 Vimal Guptha Residency, Nauroji Nagar- New Delhi 110029

Phone : 0975-3583, 0976-2833

editor@jcdronline.org